News

This story is part of a series on the current progression in Regenerative ... can be caused by age-related changes, trauma, inflammation, and genetics. More recently, cell therapies have emerged ...
for regenerative heart therapy. Simply put, HiPSCs are cells derived from mature cells that can be effectively ‘reprogrammed’ into a completely different cell type, such as cardiac muscle ...
Our goal for the past decade has been to make regenerative therapies the highest quality possible along with being the most affordable in the world.” — David Greene, MD, PhD, MBA SCOTTSDALE ...
iPSCs are being tested for various conditions, including Parkinson's disease, cancer immunotherapies with iNK cells, age-related ... Cellular Therapy: iPSCs are being explored for cell therapy ...
In vision diseases such as age-related macular ... on the disease, the cell type, and that cell type’s location in the eye. Tenpoint represents an assembly of cell therapy technologies from ...
are advancing novel regenerative medicines capable of repairing tissues damaged by age-related disease. In contrast to cell therapies, these first-in-class small molecule drugs—several of which ...
N.J.--(BUSINESS WIRE)--Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing a novel adult retinal pigment epithelial stem cell (RPESC) therapy for dry age-related ...
Studies like this one show the promise of cell therapy for treating incurable conditions ... younger adults continue to rise, chemotherapy-related infertility rates are expected to rise as ...
A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being granted approval for a registrational Phase I clinical trial.
Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy. Cell Stem Cell , 2024; DOI: 10.1016/j.stem.2024.11.010 Cite This Page : ...
plans to convene a panel of outside experts before deciding on the company's cell therapy for a heart condition related to Duchenne muscular dystrophy (DMD). Shares of the drug developer fell ...